
Cryptococcemia in a patient with COVID‐19: A case report
Author(s) -
Khatib Mohamad Y.,
Ahmed Amna A.,
Shaat Said B.,
Mohamed Ahmed S.,
Nashwan Abdulqadir J.
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.3668
Subject(s) - medicine , tocilizumab , covid-19 , intensive care medicine , virology , disease , infectious disease (medical specialty) , outbreak
The authors urge clinicians to balance the use of Immunosuppressant drugs and tocilizumab for COVID‐19 patients to avoid the development of infections like Cryptococcemia, leading to death within 30 days.